Purpose: Repair of radiation-induced DNA damage plays a critical role for both the susceptibility of patients to side effects after radiotherapy and their subsequent cancer risk.The study objective was to evaluate whether DNA repair data determined in vitro are correlated with the occurrence of acute side effects during radiotherapy. Experimental Design: Nasopharyngeal cancer patients receiving radiation therapy were recruited in a prospective epidemiologic study. As an indicator for clinical radiosensitivity, adverse reactions of the skin were recorded. Cryopreserved lymphocytes from 100 study participants were g-irradiated with 5 Gy in vitro and analyzed using the alkaline comet assay. Reproducibility of the assay was determined by repeated analysis (n = 22) of cells from a healthy donor. A coefficient of variation of 0.24 was calculated. Results: The various parameters determined to characterize the individual DNA repair capacity showed large differences between patients. Twenty-one patients were identified with considerably enhanced DNA damage induction, and 19 patients exhibited severely reduced DNA repair capacity after 15 and 30 minutes. Eight patients were considered as clinically radiosensitive, indicated by moist desquamation of the skin after a total radiation dose of 70 Gy. Conclusions: Using the alkaline comet assay as described here, nasopharyngeal cancer patients were identified showing abnormal cellular radiation effects, but this repair deficiency corresponded only at a very limited extent to the acute radiation sensitivity of the skin.Despite various therapeutic improvements, efficient radiation therapy of malignant cancers is limited by the adverse side effects occurring in the normal tissue when exposed to radiation. In general, >15% of nasopharyngeal cancer patients develop acute or late symptoms of enhanced radiosensitivity (1, 2). Several patient-and treatment-related factors are known to influence the variability of side effects; however, up to 70% of the cases remain unexplained (1). Therefore, there is much interest among clinicians for in vitro detection of cellular radiosensitivity as an indicator of the extent of a patient's normal tissue reaction (3). The use of such predictive assays would enable clinicians to adjust radiation therapy for both sensitive and resistant patients (4) with consequent improvement in the therapeutic ratio (5). For example, a strategy based on testing human normal tissue radiosensitivity to identify the patients with a high risk of developing unacceptable severe reactions after radiotherapy might also permit the individualization of treatment (5) by dose escalation in resistant patients without increasing normal tissue complications (6 -8).Three biological parameters have been used mainly to determine radiosensitivity in vitro. Data from assays based on clonogenic survival (9 -12) and chromosomal aberrations (11,12) showed, at least in several studies, a good correlation of in vitro data with late radiation effects, but these assays are time consu...